Dopamine and Norepinephrine Reuptake Inhibitor class drugs

1 result
  • sunosi

    (solriamfetol)
    Axsome Therapeutics, Inc.
    SUNOSI is indicated for improving wakefulness in adults with excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea (OSA). It is not a treatment for the underlying airway obstruction in OSA; those treatments must continue during SUNOSI use.